Abstract
Patients with juvenile idiopathic arthritis (JIA) present with varying degrees of long-term joint sequelae; those with polyarticular involvement generally have longer periods of disease activity and greater long-term joint damage than do patients with oligoarthritis. When early treatment with nonsteroidal anti-inflammatory agents (NSAIDs) is not effective, corticosteroids or disease modifying antirheumatic drugs (DMARDs) such as methotrexate (MTX), …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
